Janssen-Cilag SpA
Clinical Trials
14
Trial Phases
3 Phases
Drug Approvals
9
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)โข Click on a phase to view related trials
A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Janssen-Cilag S.p.A.
- Target Recruit Count
- 372
- Registration Number
- NCT04567602
- Locations
- ๐ฎ๐น
Generale Regionale F. Miulli, Acquaviva Delle Fonti, Italy
๐ฎ๐นA.O. Universitaria Ospedali Riuniti di Ancona, Ancona, Italy
๐ฎ๐นAzienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Bari, Italy
A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in Italy
- Conditions
- Depressive Disorder, MajorSuicidal Ideation
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen-Cilag S.p.A.
- Target Recruit Count
- 136
- Registration Number
- NCT04463108
- Locations
- ๐ฎ๐น
Ospedale S Francesco d Assisi, Oliveto Citra, Italy
๐ฎ๐นASST Spedali Civili Brescia, Brescia, Italy
๐ฎ๐นOspedale Santissima Trinitร , Cagliari, Italy
A Study of Guselkumab in Naive or Bio-experienced Participants With Regional (Facial and Genital) Psoriasis
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Janssen-Cilag S.p.A.
- Target Recruit Count
- 356
- Registration Number
- NCT04439526
- Locations
- ๐ฎ๐น
Policlinico di Bari Ospedale Giovanni XXIII, Bari, Italy
๐ฎ๐นPoliclinico Sant'Orsola Malpighi, Bologna, Italy
๐ฎ๐นOspedale San Giovanni di Dio, Cagliari, Italy
A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting
- First Posted Date
- 2018-10-25
- Last Posted Date
- 2022-01-03
- Lead Sponsor
- Janssen-Cilag S.p.A.
- Target Recruit Count
- 312
- Registration Number
- NCT03720561
- Locations
- ๐ฎ๐น
Ospedali Riuniti Di Ancona, Ancona, Italy
๐ฎ๐นU.O.C. Ematologia e Terapia Cellulare Ospedale C e G Mazzoni, Ascoli Piceno, Italy
๐ฎ๐นU.O. Ematologia con Trapianto- AOU Policlinico di Bari, Bari, Italy
An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate
- Conditions
- Human Immunodeficiency Virus (HIV)
- Interventions
- Drug: D/C/F/TAF Fixed-Dose Combination (FDC)
- First Posted Date
- 2018-07-05
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Janssen-Cilag S.p.A.
- Target Recruit Count
- 246
- Registration Number
- NCT03577470
- Locations
- ๐ฎ๐น
A O Universitaria Senese Ospedale Santa Maria alle Scotte, Siena, Italy
๐ฎ๐นAzienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
๐ฎ๐นAzienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy
- Prev
- 1
- 2
- 3
- Next